Trials / Completed
CompletedNCT00285623
Observational Cohort Study of TachoSil (TC-018-IN)
An Non-interventional, Prospective, Non-controlled Study of the Use of TachoSil in Supportive Treatment in Surgery for Improvement of Haemostasis Where Standard Techniques Are Insufficient.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 3,000 (actual)
- Sponsor
- Nycomed · Industry
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to collect information, after exposure to TachoSil ®, of all thromboembolic events, immunological events and drug interactions leading to thromboembolic events or major bleeding. In addition, pharmacoeconomic data will be collected.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Fibrinogen (human) + thrombin (human) (TachoSil) | treatment in surgery for improvement of haemostasis where standard techniques are insufficient |
Timeline
- Start date
- 2005-12-01
- Primary completion
- 2008-04-01
- Completion
- 2008-07-01
- First posted
- 2006-02-02
- Last updated
- 2012-05-07
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT00285623. Inclusion in this directory is not an endorsement.